Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients

PURPOSE: Patients with chronic myeloid leukemia (CML) who present a sustained deep molecular response (DMR) for a stable period of time might benefit from discontinuing tyrosine kinase inhibitors (TKIs). A significant number of patients seem able to reach this stage due to the availability of TKIs....

Descripción completa

Detalles Bibliográficos
Autores principales: Cutica, Ilaria, Riva, Silvia, Orlandi, Ester Maria, Iurlo, Alessandra, Vener, Claudia, Elena, Chiara, Bucelli, Cristina, Cattaneo, Daniele, Tomezzoli, Elisa, Pravettoni, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635475/
https://www.ncbi.nlm.nih.gov/pubmed/36338243
http://dx.doi.org/10.2147/PPA.S369326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635475/
https://www.ncbi.nlm.nih.gov/pubmed/36338243
http://dx.doi.org/10.2147/PPA.S369326

Ejemplares similares